US20020002270A1 - Purified antigen for alzheimer's disease, and methods of obtaining and using same - Google Patents

Purified antigen for alzheimer's disease, and methods of obtaining and using same Download PDF

Info

Publication number
US20020002270A1
US20020002270A1 US09/334,582 US33458299A US2002002270A1 US 20020002270 A1 US20020002270 A1 US 20020002270A1 US 33458299 A US33458299 A US 33458299A US 2002002270 A1 US2002002270 A1 US 2002002270A1
Authority
US
United States
Prior art keywords
antigen
preparation
autoantibodies
a68
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/334,582
Inventor
Raymond P. Zinkowski
Daniel J. Kerkman
Russell E. Kohnken
John F. DeBernardis
Peter Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Geriatrics Corp
Original Assignee
Molecular Geriatrics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Geriatrics Corp filed Critical Molecular Geriatrics Corp
Priority to US09/334,582 priority Critical patent/US20020002270A1/en
Assigned to MOLECULAR GERIATRICS CORPORATION reassignment MOLECULAR GERIATRICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DAVIES, PETER, DEBERNARDIS, JOHN F., KERKMAN, DANIEL J., KOHNKEN, RUSSELL E., ZINKOWSKI, RAYMOND P.
Publication of US20020002270A1 publication Critical patent/US20020002270A1/en
Application status is Abandoned legal-status Critical

Links